Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
Red marrow dosimetry is essential during radioimmunotherapy and a reliable method is essential in order to find a measure correlated to the toxic effect observed. The aim of this study was to calculate the absorbed dose to red marrow with different methods for the same patients and to compare the results. Patients diagnosed with B-cell lymphoma were treated with (131)I-labelled monoclonal antibodies (LL2, anti-CD22). Blood samples were collected, scintillation camera images were taken and single probe measurements were carried out at different points in time after administration of the radiopharmaceutical. The absorbed dose to red marrow per unit activity administered was calculated using four varieties of the blood method and from activity quantification in the sacrum in the scintillation camera images. The absorbed dose to the total body per unit activity, sometimes used as a measure for determining the toxic effect in red marrow, was calculated from both the scintillation camera images and the single probe measurements. The results from the different methods of calculating the absorbed dose for the same patient and treatment were compared. The ratio of the maximum and the minimum absorbed dose to red marrow calculated using the four variations of the blood method and the sacrum imaging method for one and the same patient varied between 1.8 and 2.8. The correlation coefficients for all the possible combinations of the dosimetry methods, including total body measurements, varied from 0.51 to 0.99. The results show that the variability of the absorbed dose to the bone marrow is dependent on both method and patient.
Hindorf
Cecilia
C
Department of Medical Radiation Physics, Lund University, Sweden. cecilia.hindorf@icr.ac.uk
Lindén
Ola
O
Tennvall
Jan
J
Wingårdh
Karin
K
Strand
Sven-Erik
SE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001769:Blood / Q000528:radiation effects*; D001853:Bone Marrow / Q000528:radiation effects*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000532:radiotherapy*; D051379:Mice; D011829:Radiation Dosage; D016499:Radioimmunotherapy / Q000379:methods*; D011874:Radiometry / Q000379:methods; D012447:Sacrum / Q000528:radiation effects; D051918:Sialic Acid Binding Ig-like Lectin 2 / Q000276:immunology*
D000911:Antibodies, Monoclonal; C497868:Cd22 protein, mouse; D007457:Iodine Radioisotopes; D051918:Sialic Acid Binding Ig-like Lectin 2